Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. 1997 Mar; 99(3):454-61.

View in: PubMed

subject areas

Bronchiolitis
Bronchiolitis
Bronchopulmonary Dysplasia
Bronchopulmonary Dysplasia
Child, Preschool
Child, Preschool
Double-Blind Method
Double-Blind Method
Follow-Up Studies
Follow-Up Studies
Heart Defects, Congenital
Heart Defects, Congenital
Hospitalization
Hospitalization
Humans
Humans
Immunoglobulins, Intravenous
Immunoglobulins, Intravenous
Infant
Infant
Infant, Newborn
Infant, Newborn
Infant, Premature
Infant, Premature
Pneumonia, Viral
Pneumonia, Viral
Respiratory Syncytial Virus Infections
Respiratory Syncytial Virus Infections
Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus, Human
Risk Factors
Risk Factors
Treatment Outcome
Treatment Outcome